Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019
2019년 코로나바이러스 질병의 정맥 혈전증, 혈전색전증, 염증의 바이오마커 및 응고
Observational Study
[키워드] 95% CI
95% confidence interval
active malignancy
Admission
age
biomarkers of inflammation
C-reactive protein
Clinical outcome
clinical outcomes
Coagulation
cohort study
conducted
coronavirus disease
Coronavirus disease 2019
Course
COVID-19
COVID-19 patient
COVID-19 patients
Cox proportional hazard
CRP
D-dimer
death
Deep vein
Deep vein thrombosis
Disseminated intravascular coagulation
Effect
elevated
evaluate
Evidence
evidence of
fibrinogen
hazard ratio
In-hospital
incidence
increase in
independent predictor
independent predictors
Inflammatory
intravascular coagulation
intubation
Laboratory
Laboratory features
linear
Logistic
Male sex
malignancy
marker
medical record
medical records
multivariable analysis
Observational cohort study
Odds ratio
Older age
outcome
outcomes
partial thromboplastin time
Patient
patients hospitalized
Platelet
Platelet count
prothrombin
Prothrombin time
Pulmonary embolism
remained
retrospective
retrospective observational cohort study
Seven
Sex
Thromboembolism
THROMBOPLASTIN
thrombosis
thrombotic
Thrombotic events
troponin T
ultrasound examination
univariable analysis
Venous Thromboembolism
Venous thrombosis
VTE
were used
with COVID-19
[DOI] 10.1016/j.jvsv.2020.11.006 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1016/j.jvsv.2020.11.006 PMC 바로가기 [Article Type] Observational Study